Founded in 1999, PELVIPHARM is a contract research organization (CRO) relying on multi-disciplinary talents (medical doctor, pharmaco-economist, veterinarian, pharmacists and PhDs) who deliver both high quality academic standards and reliable contract research services :
- Preclinical studies based on validated efficacy models including delivery of protocol development, study conduct, report, communication and peer-reviewed publication
- Guidance for selection of new chemical entities including testing with targeted assays according to potential mechanisms of action
- Identification of new properties or attributes supporting differentiation of medications within the class or between classes
- Advice in clinical development for new therapeutic indications or enhancements to address unmet medical need or significant commercial opportunities
PELVIPHARM
has leading scientific and medical capabilities from unique expertise and experience in pathophysiology, pharmacology, clinical research and medical practice across a range of therapeutic areas including urology (BPH, OAB, NDO, SCI, SUI, IC …), sexual (ED, PE, FSD …) and cardiovascular medicine (Hypertension, Atherosclerosis, Metabolic Syndrome, Diabetes, Myocardial Infarction …) :

PELVIPHARM provides customized services to clients according to their outsourcing needs, using experimental models based on the most recent exploration methods.
PELVIPHARM can give you the unique expertise and the experience of a team gathered over the years.
News and next meetings
Report on human sexuality and pharmacology of sexual dysfunctions. Interview of Professor François ......
Future presentation at the ISSWSH
Pelvipharm at the ISSWSH (International Society for the Study of Women’s Sexual Health) in St. Peter......
Recently accepted paper in J Sex Med
Neuroanatomical evidence for a role of central melanocortin-4 receptors and oxytocin in the efferent......
Future presentations at the EAU
Pelvipharm at the EAU (European Association of Urology) in Barcelona, Spain, 16 - 20 April 2010. P......
BIO-Europe Spring meeting in Barcelona, March 2010
Pelvipharm will be represented by Delphine Behr-Roussel at the next BIO-Europe Spring meeting in Bar......
Latest website updates
New abstract/poster available at download
"How does chronic sildenafil prevent vascular oxidative stress in insulin resistant rats?" presented at the ESSM 2009 in Lyon, 16 november , 2009 (Oral presentation).
New experimental skills developed
Recording of bladder afferent firing in rats
New model developped



To schedule a meeting, please contact us